Loading...
Cost-Effectiveness of Chemoprevention with Proton Pump Inhibitors in Barrett’s Esophagus
BACKGROUND: Proton pump inhibitors (PPIs) may reduce the risk of esophageal adenocarcinoma (EAC) in patients with Barrett’s esophagus. PPIs are prescribed for virtually all patients with Barrett’s esophagus, irrespective of the presence of reflux symptoms, and represent a de facto chemopreventive ag...
Saved in:
| Published in: | Dig Dis Sci |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
2014
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4315516/ https://ncbi.nlm.nih.gov/pubmed/24795040 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10620-014-3186-3 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|